Amy Walker

Company: 4basebio

Job title: Vice President and Director - Discovery Research and Business Development

Seminars:

Novel, Synthetic DNA Templates Enable Expedited Turnaround Times for mRNA Cancer Vaccines 2:00 pm

mRNA production is limited by availability of high-quality, GMP-grade DNA. Synthetic DNA produced enzymatically can address the drawbacks associated with plasmid derived DNA templates. The use of synthetic DNA templates can greatly reduce the needle-to-needle time in oncology vaccine applications. opDNA is a synthetic DNA template with a 3’ open end, which can feed directly…Read more

day: Conference Day One